Van Cutsem, E <br/><br/>
Irinotecan versus infusional 5-fluorouracil: a phase III study in metastatic colorectal cancer following failure on first-line 5-fluorouracil. V302 Study Group.  [electronic resource] 

 -  Seminars in oncology  Feb 1999 
 - 13-20 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0093-7754 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antimetabolites, Antineoplastic--therapeutic use<br/>Antineoplastic Agents, Phytogenic--therapeutic use<br/>Camptothecin--analogs & derivatives<br/>Colorectal Neoplasms--drug therapy<br/>Female<br/>Fluorouracil--therapeutic use<br/>Humans<br/>Irinotecan<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Neoplasm Metastasis<br/>Quality of Life<br/>Survival Analysis<br/>Topoisomerase I Inhibitors<br/>Treatment Failure